These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 30988666)

  • 21. Identification of extracellular matrix protein 1 as a potential plasma biomarker of ESCC by proteomic analysis using iTRAQ and 2D-LC-MS/MS.
    Wang X; Peng Y; Xie M; Gao Z; Yin L; Pu Y; Liu R
    Proteomics Clin Appl; 2017 Sep; 11(9-10):. PubMed ID: 28493612
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma.
    Abudureheman A; Ainiwaer J; Hou Z; Niyaz M; Turghun A; Hasim A; Zhang H; Lu X; Sheyhidin I
    J Cancer Res Clin Oncol; 2018 Jun; 144(6):1025-1035. PubMed ID: 29532228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prognostic role of FZD6 in esophageal squamous cell carcinoma patients.
    Zhang J; Wang JL; Zhang CY; Ma YF; Zhao R; Wang YY
    Clin Transl Oncol; 2020 Jul; 22(7):1172-1179. PubMed ID: 31748958
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of Sirtuin-1 is associated with poor clinical outcome in esophageal squamous cell carcinoma.
    He Z; Yi J; Jin L; Pan B; Chen L; Song H
    Tumour Biol; 2016 Jun; 37(6):7139-48. PubMed ID: 26662958
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD82/KAI1 inhibits invasion and metastasis of esophageal squamous cell carcinoma via TGF-β1.
    Zeng TD; Zheng B; Zheng W; Chen C
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5928-5937. PubMed ID: 30280774
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Caveolin-1 affects tumor drug resistance in esophageal squamous cell carcinoma by regulating expressions of P-gp and MRP1.
    Zhang S; Cao W; Yue M; Zheng N; Hu T; Yang S; Dong Z; Lu S; Mo S
    Tumour Biol; 2016 Jul; 37(7):9189-96. PubMed ID: 26768616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of miR-375 as a potential prognostic biomarker for esophageal squamous cell cancer: A bioinformatics analysis based on TCGA and meta-analysis.
    Luo HS; Wu DH
    Pathol Res Pract; 2019 Mar; 215(3):512-518. PubMed ID: 30638952
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Profiling of differentially expressed cancer-related genes in esophageal squamous cell carcinoma (ESCC) using human cancer cDNA arrays: overexpression of oncogene MET correlates with tumor differentiation in ESCC.
    Hu YC; Lam KY; Law S; Wong J; Srivastava G
    Clin Cancer Res; 2001 Nov; 7(11):3519-25. PubMed ID: 11705871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of prothymosin alpha predicts early recurrence and poor prognosis of hepatocellular carcinoma.
    Ha SY; Song DH; Hwang SH; Cho SY; Park CK
    Hepatobiliary Pancreat Dis Int; 2015 Apr; 14(2):171-7. PubMed ID: 25865690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of CD9 correlates with tumor stage and lymph node metastasis in esophageal squamous cell carcinoma.
    Huan J; Gao Y; Xu J; Sheng W; Zhu W; Zhang S; Cao J; Ji J; Zhang L; Tian Y
    Int J Clin Exp Pathol; 2015; 8(3):3054-61. PubMed ID: 26045817
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pyk2 level is a novel prognostic marker for patients with esophageal squamous cell carcinoma after radical surgery.
    Zhu T; Yang Q; Shao J; Chen Z; Cai B; Mao G
    Virchows Arch; 2021 Nov; 479(5):905-917. PubMed ID: 34313839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Using proteomic approach to identify tumor-associated proteins as biomarkers in human esophageal squamous cell carcinoma.
    Zhang J; Wang K; Zhang J; Liu SS; Dai L; Zhang JY
    J Proteome Res; 2011 Jun; 10(6):2863-72. PubMed ID: 21517111
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative Dot Blot (QDB) as a universal platform for absolute quantification of tissue biomarkers.
    Zhang W; Yu G; Zhang Y; Tang F; Lv J; Tian G; Zhang Y; Liu J; Mi J; Zhang J
    Anal Biochem; 2019 Jul; 576():42-47. PubMed ID: 30974091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. KIF4A enhanced cell proliferation and migration via Hippo signaling and predicted a poor prognosis in esophageal squamous cell carcinoma.
    Sun X; Chen P; Chen X; Yang W; Chen X; Zhou W; Huang D; Cheng Y
    Thorac Cancer; 2021 Feb; 12(4):512-524. PubMed ID: 33350074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of ATPase Na+/+ transporting alpha 1 polypeptide, ATP1A1, correlates with clinical diagnosis and progression of esophageal squamous cell carcinoma.
    Wu IC; Chen YK; Wu CC; Cheng YJ; Chen WC; Ko HJ; Liu YP; Chai CY; Lin HS; Wu DC; Wu MT
    Oncotarget; 2016 Dec; 7(51):85244-85258. PubMed ID: 27845894
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genome-wide gene expression profile analyses identify CTTN as a potential prognostic marker in esophageal cancer.
    Lu P; Qiao J; He W; Wang J; Jia Y; Sun Y; Tang S; Fu L; Qin Y
    PLoS One; 2014; 9(2):e88918. PubMed ID: 24551190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative Proteomics Identify the Possible Tumor Suppressive Role of Protease-Activated Receptor-4 in Esophageal Squamous Cell Carcinoma Cells.
    Wang M; An S; Wang D; Ji H; Geng M; Guo X; Wang Z
    Pathol Oncol Res; 2019 Jul; 25(3):937-943. PubMed ID: 29502225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Promoter hypomethylation mediated upregulation of MicroRNA-10b-3p targets FOXO3 to promote the progression of esophageal squamous cell carcinoma (ESCC).
    Lu YF; Yu JR; Yang Z; Zhu GX; Gao P; Wang H; Chen SY; Zhang J; Liu MY; Niu Y; Wei XM; Wang W; Ye FJ; Zhang LX; Zhao Y; Sun GG
    J Exp Clin Cancer Res; 2018 Dec; 37(1):301. PubMed ID: 30514328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tenascin-C, a Prognostic Determinant of Esophageal Squamous Cell Carcinoma.
    Yang ZT; Yeo SY; Yin YX; Lin ZH; Lee HM; Xuan YH; Cui Y; Kim SH
    PLoS One; 2016; 11(1):e0145807. PubMed ID: 26731558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comprehensive bioinformatics analysis identifies lncRNA HCG22 as a migration inhibitor in esophageal squamous cell carcinoma.
    Li X; Xiao X; Chang R; Zhang C
    J Cell Biochem; 2020 Jan; 121(1):468-481. PubMed ID: 31236983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.